Delhi, Delhi India (PressExposure) January 08, 2008 -- According to a new research report released recently by the leading market research firm RNCOS "Global Vaccine Market Outlook (2007-2010)", the global vaccine market, characterized by sluggish growth, is seeing an upturn due to launch of new paediatric vaccines and the booming influenza vaccine markets in the US and Europe. It has identified the US as the largest vaccine market globally followed by Europe. During 2003 to 2006, as the report says, the US vaccine market grew at a projected CAGR of 9.3% and is anticipated to maintain the same rate till 2008 with the launch of several developmental vaccines in the market.
However, despite this sound growth rate, the number of vaccine makers has slipped down to a few in the US from the past three decades. The RNCOS research has tried to find out the reasons behind this rather surprising trend observed in the US market.
Also, flu vaccine is considered very important in the US. Earlier in September 2007, the US Food and Drug Administration (FDA) approved an additional seasonal flu vaccine to immunize adults (18 years and above) against type A and B flu viruses. The report has thoroughly studied the market to come up with the factors that are making flu vaccines so vital for the US vaccine market. It also highlights the measures and actions being taken by the US government to combat the rising problem of influenza infection.
The RNCOS study has analyzed the market to look for various vaccines in the development stages and for which specific diseases they are meant for. It has also studied the various vaccine groups to define the ones that will record fastest growth in the US human vaccines market.
The US vaccine market is just one of the many markets discussed in the descriptive "Global Vaccine Market Outlook (2007-2010)". The other markets include Japan, China, Brazil, and India. It briefly discusses the regulatory framework, intellectual property rights, market performance of various vaccine segments and vaccines, and gives an insight into the forces, opportunities and challenges for the global vaccine market. After rationally evaluating the global market, RNCOS has presented a future forecast of the market and its various segments.